Carvedilol and Alverine in Portal Hypertension

Clinical trial NCT06696248 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06696248
Sponsor: Shanghai Changzheng Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hypertension, Portal

Start date: 2024-11-15
Primary completion: 2025-09-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.